Search

Search Constraints

You searched for: Author/Creator Brunner, Andrew M.

Search Results

1. A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies. Issue 2 (6th March 2022)

2. A phase 1 study of the antibody‐drug conjugate brentuximab vedotin with re‐induction chemotherapy in patients with CD30‐expressing relapsed/refractory acute myeloid leukemia. Issue 6 (20th December 2019)

3. A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes. Issue 2 (10th November 2022)

4. A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia. Issue 2 (21st November 2017)

7. Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemia. Issue 8 (30th May 2013)

8. Association between insurance status at diagnosis and overall survival in chronic myeloid leukemia: A population‐based study. Issue 13 (2nd May 2017)

10. Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance‐conferring FLT3/tyrosine kinase domain/F691 mutation. Issue 2 (28th September 2017)